1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Respiratory Therapy News DECEMBER 2014

Respiratory Therapy News DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 8 pages

Industry Brief - BeyondSpring To Initiate Plinabulin Phase III Trial In NSCLC
Industry Brief - FDA Grants Fast Track Designation To Novavax' RSV F Vaccine
Industry Brief - FDA Grants QIDP Designation To Bayer's Amikacin Inhale/Ciprofloxacin DPI
Industry Brief - CHMP Issues Positive Opinion For BI's Nintedanib In IPF
Industry Brief - EC Approves BI's Vargatef For NSCLC After First-Line Chemotherapy
Industry Brief - Teva Launches Erlotinib In Canada
Industry Brief - Dosing Begins In OncoMed's Tarextumab Phase II Trial For SCLC
Industry Brief - Dynavax/AstraZeneca To Advance AZD1419 Into Phase IIa Asthma Study
Industry Brief - flutiform Now Available In Spain And Italy
Industry Brief - FDA Accepts AstraZeneca's NDA Filing For Iressa
Industry Brief - Lung Therapeutics' LTI-01 Gains FDA ODD For Empyema
Industry Brief - Basilea Launches Zevtera In Germany
Industry Brief - Kyorin Markets flutiform 120-Puff Version In Japan
Industry Brief - Pfizer Launches Ultibro Breezhaler In UK
Industry Brief - Actelion Submits EU MAA For Selexipag In PAH
Industry Brief - GSK Seeks European Approval For Extended Indication Of Volibris
Industry Brief - FDA Approves Cyramza For Second-Line mNSCLC

Table Of Contents

Respiratory Therapy News DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.